SCHEMBL4089867

SCHEMBL4089867

CCc1c(OCc2ccccc2)cccc1-c1cccc(CC(=O)O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 7/20 0.61
PTGER4 P35408 5/20 0.61
PTGER3 P43115 5/20 0.61
PTGER2 P43116 5/20 0.61
CFD P00746 2/20 0.51
F11 P03951 2/20 0.51
TPSB2 P20231 2/20 0.51
PLG P00747 1/20 0.51
PLAU P00749 1/20 0.51
KLKB1 P03952 1/20 0.51
F7 P08709 1/20 0.51
SELL P14151 1/20 0.51
SELP P16109 1/20 0.51
TBXA2R P21731 1/20 0.50
FFAR1 O14842 3/20 0.48
MCL1 Q07820 1/20 0.47
ENPP2 Q13822 1/20 0.46
SLC22A12 Q96S37 1/20 0.46
RXRB P28702 3/20 0.46
RXRA P19793 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4089863 0.79 PTGER4 (0.59) PTGER1PTGER4PTGER3PTGER2CFD
SCHEMBL2587121 0.78 SELL (0.62) PTGER1PTGER4PTGER3PTGER2SELL
SCHEMBL17187933 0.77 PLA2G10 (0.60) PTGER1PTGER4PTGER3PTGER2SELL
SCHEMBL5095987 0.76 PTGER1 (0.76) PTGER1PTGER4PTGER3PTGER2TBXA2R
SCHEMBL3839813 0.75 PLA2G10 (0.58) PTGER1PTGER4PTGER3PTGER2SELL
SCHEMBL4383171 0.75 PTGER1 (0.48) PTGER1PTGER4PTGER3PTGER2CFD
SCHEMBL3413422 0.75 SMPD1 (0.57) PTGER1PTGER4PTGER3PTGER2CFD
SCHEMBL8845892 0.74 PTGER1 (0.56) PTGER1PTGER4PTGER3PTGER2CFD
SCHEMBL3908596 0.73 CFD (0.66) CFDF11TPSB2PLGPLAU
SCHEMBL6034660 0.73 RXRA (0.56) PTGER1PTGER4PTGER3PTGER2RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553867-B2 Furan or thiophene derivative and medicinal use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-30 US disclosed
US-20060100261-A1 Furan or thiopene derivative and medicinal use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED INTELLECTUAL PROPERTY DEPARTMENT (JP) 2006-05-11 US disclosed
EP-1535915-A1 FURAN OR THIOPHENE DERIVATIVE AND MEDICINAL USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100261-A1 Furan or thiopene derivative and medicinal use thereof TXN2, CYP11B2, CYP11B1 PTGER1 29/4885PTGER4 115/4885PTGER3 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.